Status:
TERMINATED
Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")
Lead Sponsor:
Sansum Diabetes Research Institute
Collaborating Sponsors:
Hass Avocado Board
Conditions:
Dietary Habits
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hispanic/Latino adults in the United States (U.S.) bear a disproportionate burden of type 2 diabetes (T2D). Dietary changes, facilitated by increased access and adherence to healthy foods, are necessa...
Detailed Description
In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic control in Hispanic/Latino adults with and at-risk of T2D before and after receiving free avocado vouche...
Eligibility Criteria
Inclusion
- Adults ≥ 18 years of age at enrollment.
- Self-reported Hispanic/Latino heritage.
- Self-reported diagnosis of T2D or self-reported as at risk for developing T2D using the American Diabetes Association diabetes risk assessment tool \[25\].
Exclusion
- Use of insulin
- Pregnancy
- Any active clinically significant disease or disorder which in the investigator's opinion could interfere with participation in the study.
Key Trial Info
Start Date :
March 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05293340
Start Date
March 31 2022
End Date
January 31 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sansum Diabetes Research Institute
Santa Barbara, California, United States, 93105